INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early ...

(Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with ...

There are currently no approved treatments in Canada that can slow the progression of Alzheimer's, only drugs to quiet ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

In the case of the amyloid drugs, Eisai Biogen's Leqembi (lecanemab) and Eli Lilly's Kisunla (donanemab) – there are also ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

A once-a-day pill that could completely revolutionise the treatment of Alzheimer’s disease has reached a significant milestone after the Australian biotech firm behind the potential wonder drug ...

Cognition Therapeutics Inc (NASDAQ: CGTX) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge ...

Gene discovery may lead to ‘exercise pill’ for Alzheimer’s patients - Researchers could alter function of newborn nerve cells ...

Digging into a prespecified analysis for the mid-stage study, INmune Bio identified some clinical and biological benefits of ...